Loading...
Biosimilars: Considerations for Payers
Evaluating biosimilars requires payers to go beyond cost considerations: safety and efficacy, reliability of supply and logistics, and the impact of state laws on substitution and interchangeability must all be deliberated.
Saved in:
| Published in: | P T |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MediMedia USA, Inc.
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355057/ https://ncbi.nlm.nih.gov/pubmed/30766011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|